David A Jaffray
Overview
Explore the profile of David A Jaffray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
4938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaffray D, Coppes R, McNair H, Viswanathan A
Semin Radiat Oncol
. 2024 Sep;
34(4):367-369.
PMID: 39271271
No abstract available.
2.
Sujit S, Aminu M, Karpinets T, Chen P, Saad M, Salehjahromi M, et al.
Nat Commun
. 2024 Apr;
15(1):3152.
PMID: 38605064
While we recognize the prognostic importance of clinicopathological measures and circulating tumor DNA (ctDNA), the independent contribution of quantitative image markers to prognosis in non-small cell lung cancer (NSCLC) remains...
3.
Qin K, Wang K, Li S, Hong L, Padmakumar P, Waree R, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473297
Docetaxel +/- ramucirumab remains the standard-of-care therapy for patients with metastatic non-small-cell lung cancer (NSCLC) after progression on platinum doublets and immune checkpoint inhibitors (ICIs). The aim of our study...
4.
Guckenberger M, Andratschke N, Chung C, Fuller D, Tanadini-Lang S, Jaffray D
Semin Radiat Oncol
. 2023 Dec;
34(1):135-144.
PMID: 38105088
Magnetic resonance image guided radiation therapy (MRIgRT) is a relatively new technology that has already shown outcomes benefits but that has not yet reached its clinical potential. The improved soft-tissue...
5.
Gospodarowicz M, Dare A, Jaffray D
Lancet Oncol
. 2023 Nov;
24(12):1297-1298.
PMID: 37924822
No abstract available.
6.
Jaffray D, Knaul F, Baumann M, Gospodarowicz M
Nat Cancer
. 2023 Sep;
4(9):1228-1238.
PMID: 37749355
The pace of technological innovation over the past three decades has transformed the field of radiotherapy into one of the most technologically intense disciplines in medicine. However, the global barriers...
7.
Baroudi H, Brock K, Cao W, Chen X, Chung C, Court L, et al.
Diagnostics (Basel)
. 2023 Feb;
13(4).
PMID: 36832155
Developers and users of artificial-intelligence-based tools for automatic contouring and treatment planning in radiotherapy are expected to assess clinical acceptability of these tools. However, what is 'clinical acceptability'? Quantitative and...
8.
Li W, Bootsma G, Shultz D, Laperriere N, Millar B, Cho Y, et al.
Phys Imaging Radiat Oncol
. 2023 Jan;
25:100415.
PMID: 36718356
As frameless stereotactic radiosurgery increase in use, the aim of this study was to evaluate intra-fraction motion through cone-beam CT (CBCT) and high-definition motion management (HDMM) systems. Intra-fraction motion measured...
9.
Jaffray D
Med Phys
. 2023 Jan;
50 Suppl 1:54-57.
PMID: 36681876
The development of cone-beam CT guided radiotherapy has transformed radiation oncology in the 20 years since it was first released commercially. The technological pace of change has spurred a massive...
10.
Sinno N, Taylor E, Hompland T, Milosevic M, Jaffray D, Coolens C
Phys Med Biol
. 2022 Dec;
67(24).
PMID: 36541560
Tumours exhibit abnormal interstitial structures and vasculature function often leading to impaired and heterogeneous drug delivery. The disproportionate spatial accumulation of a drug in the interstitium is determined by several...